Chris Mason

Chris Mason is a highly accomplished professional with a diverse educational background, holding a PhD from the Medical Research Council (MRC) Clinical Research Fellowship at UCL, an Enterprise Fellow from the Centre for Scientific Enterprise at London Business School, an MD from the United Medical & Dental Schools of Guy's & St. Thomas's Hospitals (UMDS) at King's College London, and a BSc in Clinical Sciences (Molecular Biology) with 1st Class Honors from Imperial College London.

He has held prominent positions in various organizations, notably as the Founder & Chief Scientific Officer at AVROBIO and as a former Director on the Board of Directors at Krystal Biotech, Inc. Additionally, he has served as a Professor of Cell & Gene Therapy at UCL, Founder & Director on the Board of Directors at OriBiotech Ltd., Senior Editor at Cell and Gene Therapy Insights, and Senior Editor at Regenerative Medicine.

Moreover, Chris Mason has contributed significantly to the field through roles as a Trustee at The British Neurological Research Trust and the UK Stem Cell Foundation, Chair of the Cell Therapy & Regenerative Medicine Advisory Committee at the BioIndustry Association, Founder & CEO of the London Regenerative Medicine Network, Senior Scientific Adviser at Proteus, LLC, and as a Professor of Regenerative Medicine Bioprocessing at UCL. He also has a background as an NHS Surgeon specializing in General Surgery and Cardiothoracic Surgery.